Recent Finacing
Recent Raise
HighLife develops a transseptal, femoral-vein-delivered TMVR system using a reversible two-step ring-and-bioprosthesis that self-locates within the native mitral annulus for beating-heart implantation.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at HighLife.
